BACKGROUND: There is limited information regarding the pattern and correlates of viral replication in vertically HIV-1-infected children and its role on their outcomes in resource-limited settings. METHODS: HIV-1-infected infants were followed from birth to 24 months. Serial HIV-1 RNA levels were compared in infants infected in utero (<48 hours), peripartum (48 hours-1 month), and late postnatal (after 1 month). Cofactors for viral peak [highest viral load (VL) within 6 months of infection] and set point and mortality were determined. RESULTS: Among 85 HIV-1-infected infants, 24 were infected in utero, 41 peripartum, 13 late postnatal; 7 had no 48-hour assay. HIV-1 VL set point was significantly lower in infants infected >1 month vs. < or = 1 month (5.59 vs. 6.24 log10 copies per milliliter, P = 0.01). Maternal VL correlated with peak infant VL (P < 0.001). Univariately, infant peak and set point VL and 6-month CD4% <15% predicted mortality; and 6-month CD4% <15% remained independently predictive in multivariate analyses (hazard ratio = 4.85, 95% confidence interval: 1.90 to 12.36). CONCLUSIONS: Infants infected after the age of 1 month contained virus better than infants infected before 1 month of age. Maternal VL predicted infant VL, which, in turn was associated with early mortality.
BACKGROUND: There is limited information regarding the pattern and correlates of viral replication in vertically HIV-1-infectedchildren and its role on their outcomes in resource-limited settings. METHODS:HIV-1-infectedinfants were followed from birth to 24 months. Serial HIV-1 RNA levels were compared in infants infected in utero (<48 hours), peripartum (48 hours-1 month), and late postnatal (after 1 month). Cofactors for viral peak [highest viral load (VL) within 6 months of infection] and set point and mortality were determined. RESULTS: Among 85 HIV-1-infectedinfants, 24 were infected in utero, 41 peripartum, 13 late postnatal; 7 had no 48-hour assay. HIV-1 VL set point was significantly lower in infants infected >1 month vs. < or = 1 month (5.59 vs. 6.24 log10 copies per milliliter, P = 0.01). Maternal VL correlated with peak infant VL (P < 0.001). Univariately, infant peak and set point VL and 6-month CD4% <15% predicted mortality; and 6-month CD4% <15% remained independently predictive in multivariate analyses (hazard ratio = 4.85, 95% confidence interval: 1.90 to 12.36). CONCLUSIONS:Infants infected after the age of 1 month contained virus better than infants infected before 1 month of age. Maternal VL predicted infant VL, which, in turn was associated with early mortality.
Authors: R J Biggar; M Janes; R Pilon; P Miotti; T E Taha; R Broadhead; L Mtimivalye; N Kumwenda; S Cassol Journal: J Infect Dis Date: 1999-12 Impact factor: 5.226
Authors: D Mbori-Ngacha; R Nduati; G John; M Reilly; B Richardson; A Mwatha; J Ndinya-Achola; J Bwayo; J Kreiss Journal: JAMA Date: 2001-11-21 Impact factor: 56.272
Authors: S Emery; S Bodrug; B A Richardson; C Giachetti; M A Bott; D Panteleeff; L L Jagodzinski; N L Michael; R Nduati; J Bwayo; J K Kreiss; J Overbaugh Journal: J Clin Microbiol Date: 2000-07 Impact factor: 5.948
Authors: G R Kaufmann; P Cunningham; J Zaunders; M Law; J Vizzard; A Carr; D A Cooper Journal: J Acquir Immune Defic Syndr Date: 1999-12-15 Impact factor: 3.731
Authors: J Vekemans; M O C Ota; E C Y Wang; M Kidd; L K Borysiewicz; H Whittle; K P W J McAdam; G Morgan; A Marchant Journal: Clin Exp Immunol Date: 2002-03 Impact factor: 4.330
Authors: Fatema A Legrand; Douglas F Nixon; Christopher P Loo; Erika Ono; Joan M Chapman; Maristela Miyamoto; Ricardo S Diaz; Amélia M N Santos; Regina C M Succi; Jacob Abadi; Michael G Rosenberg; Maria Isabel de Moraes-Pinto; Esper G Kallas Journal: PLoS One Date: 2006-12-20 Impact factor: 3.240
Authors: Melanie A Gasper; Pratima Kunwar; Grace Itaya; Nicholas Lejarcegui; Rose Bosire; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Jennifer Slyker; Julie Overbaugh; Helen Horton; Donald L Sodora; Grace John-Stewart; Barbara Lohman-Payne Journal: AIDS Date: 2014-05-15 Impact factor: 4.177
Authors: Kristjana H Ásbjörnsdóttir; James P Hughes; Dalton Wamalwa; Agnes Langat; Jennifer A Slyker; Hellen M Okinyi; Julie Overbaugh; Sarah Benki-Nugent; Kenneth Tapia; Elizabeth Maleche-Obimbo; Ali Rowhani-Rahbar; Grace John-Stewart Journal: AIDS Date: 2016-11-28 Impact factor: 4.177
Authors: Lara C Diener; Jennifer A Slyker; Christine Gichuhi; Kenneth A Tapia; Barbra A Richardson; Dalton Wamalwa; Carey Farquhar; Julie Overbaugh; Elizabeth Maleche-Obimbo; Grace John-Stewart Journal: AIDS Date: 2012-09-24 Impact factor: 4.177
Authors: Bhavna H Chohan; Kenneth Tapia; Michele Merkel; Arphaxad C Kariuki; Brian Khasimwa; Agatha Olago; Richard Gichohi; Elizabeth M Obimbo; Dalton C Wamalwa Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Jennifer A Slyker; Sarah L Rowland-Jones; Tao Dong; Marie Reilly; Barbra Richardson; Vincent C Emery; Ann Atzberger; Dorothy Mbori-Ngacha; Barbara L Lohman-Payne; Grace C John-Stewart Journal: J Virol Date: 2012-08-08 Impact factor: 5.103
Authors: Jennifer A Slyker; Barbara L Lohman-Payne; Grace C John-Stewart; Elizabeth Maleche-Obimbo; Sandra Emery; Barbra Richardson; Tao Dong; Astrid Kn Iversen; Dorothy Mbori-Ngacha; Julie Overbaugh; Vincent C Emery; Sarah L Rowland-Jones Journal: AIDS Date: 2009-10-23 Impact factor: 4.177
Authors: Kristjana H Ásbjörnsdóttir; Jennifer A Slyker; Noel S Weiss; Dorothy Mbori-Ngacha; Elizabeth Maleche-Obimbo; Dalton Wamalwa; Grace John-Stewart Journal: AIDS Date: 2013-11-13 Impact factor: 4.177